Product Name :
Bucolome — CYP2C9 inhibitor
Description:
Bucolome is a CYP2C9 inhibitor, used as an uricosuric agent or anti-inflammatory agent.
CAS:
841-73-6
Molecular Weight:
266.34
Formula:
C14H22N2O3
Chemical Name:
5-butyl-1-cyclohexyl-1,3-diazinane-2,4,6-trione
Smiles :
CCCCC1C(=O)N(C2CCCCC2)C(=O)NC1=O
InChiKey:
DVEQCIBLXRSYPH-UHFFFAOYSA-N
InChi :
InChI=1S/C14H22N2O3/c1-2-3-9-11-12(17)15-14(19)16(13(11)18)10-7-5-4-6-8-10/h10-11H,2-9H2,1H3,(H,15,17,19)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Taletrectinib} web|{Taletrectinib} Protein Tyrosine Kinase/RTK|{Taletrectinib} Protocol|{Taletrectinib} In stock|{Taletrectinib} supplier|{Taletrectinib} Epigenetics}
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Bucolome is a CYP2C9 inhibitor, used as an uricosuric agent or anti-inflammatory agent.|Product information|CAS Number: 841-73-6|Molecular Weight: 266.{{JS25} medchemexpress|{JS25} Protein Tyrosine Kinase/RTK|{JS25} Protocol|{JS25} Purity|{JS25} manufacturer|{JS25} Autophagy} 34|Formula: C14H22N2O3|Chemical Name: 5-butyl-1-cyclohexyl-1,3-diazinane-2,4,6-trione|Smiles: CCCCC1C(=O)N(C2CCCCC2)C(=O)NC1=O|InChiKey: DVEQCIBLXRSYPH-UHFFFAOYSA-N|InChi: InChI=1S/C14H22N2O3/c1-2-3-9-11-12(17)15-14(19)16(13(11)18)10-7-5-4-6-8-10/h10-11H,2-9H2,1H3,(H,15,17,19)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: To be determined|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.PMID:24278086 |Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Bucolome is a potent mixed-type inhibitor for (S)-warfarin 7-hydroxylation, with Ki of 8.2 and 20.2 μM, respectively.|Products are for research use only. Not for human use.|
